FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

372546009: Cytoprotective agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197839018 Cytoprotective agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211077014 Cytoprotective agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2805291000005118 Cytoprotektivt middel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cytoprotektivt middel Is a Antineoplastic agent (substance) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dexrazoxane (substance) Is a False Cytoprotektivt middel Inferred relationship Some
    Mitotane Is a False Cytoprotektivt middel Inferred relationship Some
    Resveratrol Is a False Cytoprotektivt middel Inferred relationship Some
    cytoprotektivt middel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    dexrazoxanhydrochlorid 250 mg hætteglas pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    dexrazoxanhydrochlorid 500 mg hætteglas pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Mesna 400mg/amp injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Mesna 1g injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Mesna 200mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Amifostine (substance) Is a False Cytoprotektivt middel Inferred relationship Some
    mesna 1 g injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    mesna 200 mg injektionsvæske, opløsning, ampul a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    mesna 1 g injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    mesna 400 mg/ampul injektionsvæske, opløsning, hætteglas a 4 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Razoxane 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Product containing razoxane (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Product containing mesna (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Mesna 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Mesna 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    mesna 100 mg/ml injektionsvæske, opløsning, ampul a 4 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    mesna 100 mg/ml injektionsvæske, opløsning, ampul a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some
    Product containing dexrazoxane (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytoprotektivt middel Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start